705 related articles for article (PubMed ID: 10089184)
1. Extended lymph-node dissection for gastric cancer.
Bonenkamp JJ; Hermans J; Sasako M; van de Velde CJ; Welvaart K; Songun I; Meyer S; Plukker JT; Van Elk P; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H;
N Engl J Med; 1999 Mar; 340(12):908-14. PubMed ID: 10089184
[TBL] [Abstract][Full Text] [Related]
2. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
[TBL] [Abstract][Full Text] [Related]
3. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
4. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
[TBL] [Abstract][Full Text] [Related]
5. Resection for gastric cancer in the community.
van de Velde CJ
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
[TBL] [Abstract][Full Text] [Related]
6. Gastric carcinoma: does lymph node dissection alter survival?
Wanebo HJ; Kennedy BJ; Winchester DP; Fremgen A; Stewart AK
J Am Coll Surg; 1996 Dec; 183(6):616-24. PubMed ID: 8957465
[TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
Songun I; Putter H; Kranenbarg EM; Sasako M; van de Velde CJ
Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751
[TBL] [Abstract][Full Text] [Related]
8. [D3 versus D2 dissection in stomach carcinoma. A case-control study of postoperative morbidity, survival and early oncologic outcome].
Bittorf BR; Günther F; Merkel S; Horbach T; Hohenberger W; Günther K
Chirurg; 2002 Apr; 73(4):336-47. PubMed ID: 12063918
[TBL] [Abstract][Full Text] [Related]
9. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
Roukos DH; Lorenz M; Encke A
Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
[TBL] [Abstract][Full Text] [Related]
10. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
[TBL] [Abstract][Full Text] [Related]
11. Impact of spleen preservation in patients with gastric cancer.
Fatouros M; Roukos DH; Lorenz M; Arampatzis I; Hottentrott C; Encke A; Kappas AM
Anticancer Res; 2005; 25(4):3023-30. PubMed ID: 16080561
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival is improved by an extended lymph node dissection in potentially curable gastric cancer.
Reis E; Kama NA; Doganay M; Atli M; Dolapci M
Hepatogastroenterology; 2002; 49(46):1167-71. PubMed ID: 12143228
[TBL] [Abstract][Full Text] [Related]
13. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.
Sasako M; Sano T; Yamamoto S; Kurokawa Y; Nashimoto A; Kurita A; Hiratsuka M; Tsujinaka T; Kinoshita T; Arai K; Yamamura Y; Okajima K;
N Engl J Med; 2008 Jul; 359(5):453-62. PubMed ID: 18669424
[TBL] [Abstract][Full Text] [Related]
14. [D2 lymph node dissection in gastric cancer surgery: long term results--analysis of an experience with 227 patients].
Vasilescu C; Herlea V; Tidor S; Ivanov B; Stănciulea O; Mănuc M; Gheorghe C; Ionescu M; Diculescu M; Popescu I
Chirurgia (Bucur); 2006; 101(4):375-84. PubMed ID: 17059148
[TBL] [Abstract][Full Text] [Related]
15. Limited effectiveness of extended lymph-node dissection for node-negative patients with proximal gastric cancer.
Kikuchi S; Katada N; Sakuramoto S; Kobayashi N; Shimao H; Sakakibara Y; Sato K; Kakita A
Anticancer Res; 2001; 21(2B):1359-62. PubMed ID: 11396213
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution.
Kasakura Y; Mochizuki F; Wakabayashi K; Kochi M; Fujii M; Takayama T
J Surg Res; 2002 Apr; 103(2):252-9. PubMed ID: 11922742
[TBL] [Abstract][Full Text] [Related]
17. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.
Cuschieri A; Weeden S; Fielding J; Bancewicz J; Craven J; Joypaul V; Sydes M; Fayers P
Br J Cancer; 1999 Mar; 79(9-10):1522-30. PubMed ID: 10188901
[TBL] [Abstract][Full Text] [Related]
18. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial.
Degiuli M; Sasako M; Calgaro M; Garino M; Rebecchi F; Mineccia M; Scaglione D; Andreone D; Ponti A; Calvo F;
Eur J Surg Oncol; 2004 Apr; 30(3):303-8. PubMed ID: 15028313
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patients.
Schmid A; Thybusch A; Kremer B; Henne-Bruns D
Hepatogastroenterology; 2000; 47(32):579-85. PubMed ID: 10791243
[TBL] [Abstract][Full Text] [Related]
20. Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Nagahori Y; Hosoi H; Takahashi M; Kito F; Shimada H
Ann Surg Oncol; 2006 May; 13(5):659-67. PubMed ID: 16538414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
